KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Total Current Liabilities (2016 - 2025)

Cvs Health (CVS) has disclosed Total Current Liabilities for 17 consecutive years, with $88.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 4.83% year-over-year to $88.7 billion, compared with a TTM value of $88.7 billion through Dec 2025, up 4.83%, and an annual FY2025 reading of $88.7 billion, up 4.83% over the prior year.
  • Total Current Liabilities was $88.7 billion for Q4 2025 at Cvs Health, down from $92.7 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $94.2 billion in Q2 2025 and bottomed at $59.3 billion in Q2 2021.
  • Average Total Current Liabilities over 5 years is $77.3 billion, with a median of $79.2 billion recorded in 2023.
  • The sharpest move saw Total Current Liabilities decreased 6.88% in 2021, then increased 16.1% in 2022.
  • Year by year, Total Current Liabilities stood at $67.8 billion in 2021, then grew by 2.38% to $69.4 billion in 2022, then rose by 14.07% to $79.2 billion in 2023, then increased by 6.84% to $84.6 billion in 2024, then increased by 4.83% to $88.7 billion in 2025.
  • Business Quant data shows Total Current Liabilities for CVS at $88.7 billion in Q4 2025, $92.7 billion in Q3 2025, and $94.2 billion in Q2 2025.